Health Medical Treatments
Menu
Home
About
Privacy
Disclaimer
Sitemap
Contact
Home
The Medical News
Type 1 interferon deficiency as a biomarker for detecting patients at risk of severe COVID-19
Type 1 interferon deficiency as a biomarker for detecting patients at risk of severe COVID-19
July 18, 2020
Approximately 5% of people with Covid-19 progress to a severe or critical form, including the development of severe pneumonia that progresses to acute respiratory distress syndrome.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
Newer Post
Older Post
Related Post
0 Response to "Type 1 interferon deficiency as a biomarker for detecting patients at risk of severe COVID-19"
Post a Comment
Subscribe to:
Post Comments (Atom)
Related
0 Response to "Type 1 interferon deficiency as a biomarker for detecting patients at risk of severe COVID-19"
Post a Comment